Seeking Alpha

Xilinx (XLNX) warns its FQ2 sales will decline 7-10% Q/Q, compared with prior guidance for -3%...

Xilinx (XLNX) warns its FQ2 sales will decline 7-10% Q/Q, compared with prior guidance for -3% to +1% growth. Though this expected decline is worse than the one forecast by rival Altera (ALTR), investors only appear slightly bothered by it: Xilinx is down just 0.5% premarket.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs